Matches in Wikidata for { <http://www.wikidata.org/entity/Q58000885> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q58000885 description "article scientifique publié en 2006" @default.
- Q58000885 description "article" @default.
- Q58000885 description "im Juli 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58000885 description "wetenschappelijk artikel" @default.
- Q58000885 description "наукова стаття, опублікована в липні 2006" @default.
- Q58000885 description "հոդված" @default.
- Q58000885 name "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 name "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 type Item @default.
- Q58000885 label "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 label "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 prefLabel "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 prefLabel "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 P1433 Q58000885-35A51830-0B04-4555-81C1-DDBDEB114D3F @default.
- Q58000885 P1476 Q58000885-5F4EA9C9-F34C-44AD-B098-6962B72F8C53 @default.
- Q58000885 P2093 Q58000885-0DECDC95-6342-45DA-82F5-3DD477CE62E8 @default.
- Q58000885 P2093 Q58000885-0EF59397-91A5-4BBB-9CD1-687D7E5EE772 @default.
- Q58000885 P2093 Q58000885-2F863FCD-CEC5-4AB5-BFC5-38D64E46CA03 @default.
- Q58000885 P2093 Q58000885-3A70B588-5BF3-4686-B254-56EAA775E4C1 @default.
- Q58000885 P2093 Q58000885-3BEB5CC1-473A-4DC5-BF39-233882C66BCF @default.
- Q58000885 P2093 Q58000885-9F69B41D-E09F-43E4-80F7-0A960B05E7EF @default.
- Q58000885 P2093 Q58000885-A1732A9B-9BEF-4949-86BB-16212CBCD916 @default.
- Q58000885 P2093 Q58000885-ACF75100-FD35-4DC2-9A6C-9BD7D9B712F5 @default.
- Q58000885 P304 Q58000885-38E5CE48-7BEB-4918-9425-D68EE3C8C26F @default.
- Q58000885 P31 Q58000885-604F9689-30CE-4384-9D52-71CCB7A0CD4D @default.
- Q58000885 P356 Q58000885-3415138F-9086-4BD4-9129-30F4DBD4A3A8 @default.
- Q58000885 P407 Q58000885-8D7B7773-C8BD-4781-9C23-8AB4479B336E @default.
- Q58000885 P433 Q58000885-5090A923-8DE4-4D9E-BA9C-2870FB82BC77 @default.
- Q58000885 P478 Q58000885-E40EFFE2-31D8-43EF-8C47-DB5F77ECA2A9 @default.
- Q58000885 P50 Q58000885-0C841401-E757-4E15-B92B-E423A8499B03 @default.
- Q58000885 P50 Q58000885-1D5082DD-6F34-46FA-9281-F56103234107 @default.
- Q58000885 P50 Q58000885-1EA3851A-2B64-43A1-9618-B1231F7BBED1 @default.
- Q58000885 P50 Q58000885-9E1FD438-9B36-4D62-9122-DD4FE2280D69 @default.
- Q58000885 P50 Q58000885-A004716E-66D2-4627-92DD-C2D23B5E9972 @default.
- Q58000885 P577 Q58000885-5F8F28DF-65F6-4A9C-8E1A-6678792AE304 @default.
- Q58000885 P698 Q58000885-40BD2211-5956-4F1F-815C-4150DA00763C @default.
- Q58000885 P921 Q58000885-00CF2F57-4CEB-4AC6-8AED-8D356AEA4C6D @default.
- Q58000885 P921 Q58000885-3D9313FE-8FA7-42C6-9D33-89D54985E17E @default.
- Q58000885 P921 Q58000885-678BAA83-1F99-46A0-BC0B-6514164A623F @default.
- Q58000885 P356 504872 @default.
- Q58000885 P698 16758422 @default.
- Q58000885 P1433 Q5133764 @default.
- Q58000885 P1476 "Discontinuation of Primary and SecondaryToxoplasma gondiiProphylaxis Is Safe in HIV‐Infected Patients after Immunological Restoration with Highly Active Antiretroviral Therapy: Results of an Open, Randomized, Multicenter Clinical Trial" @default.
- Q58000885 P2093 "Esteban Martinez" @default.
- Q58000885 P2093 "Jaime Cosin" @default.
- Q58000885 P2093 "Jose M. Miro" @default.
- Q58000885 P2093 "Jose M. Pena" @default.
- Q58000885 P2093 "Juan C. Alberdi" @default.
- Q58000885 P2093 "Juan C. Lopez" @default.
- Q58000885 P2093 "Miguel Santin" @default.
- Q58000885 P2093 "Pere Domingo" @default.
- Q58000885 P304 "79-89" @default.
- Q58000885 P31 Q13442814 @default.
- Q58000885 P356 "10.1086/504872" @default.
- Q58000885 P407 Q1860 @default.
- Q58000885 P433 "1" @default.
- Q58000885 P478 "43" @default.
- Q58000885 P50 Q117223591 @default.
- Q58000885 P50 Q37838345 @default.
- Q58000885 P50 Q41350341 @default.
- Q58000885 P50 Q42430889 @default.
- Q58000885 P50 Q47006509 @default.
- Q58000885 P577 "2006-07-01T00:00:00Z" @default.
- Q58000885 P698 "16758422" @default.
- Q58000885 P921 Q101929 @default.
- Q58000885 P921 Q131003 @default.
- Q58000885 P921 Q6934595 @default.